The Biotinylated Anti-TROP2 Antibody (HDLA037) is a high-quality tool for research involving the TROP2 protein, a cell surface molecule that plays a crucial role in cancer development and progression. This antibody, produced through biotinylation, is highly specific to human TROP2 and is validated for use in various applications such as immunohistochemistry and flow cytometry.TROP2, also known as tumor-associated calcium signal transducer 2, is overexpressed in various cancer types, including breast, ovarian, and lung cancers, making it a promising target for cancer therapy and diagnosis.
The Biotinylated Anti-TROP2 Antibody binds specifically to TROP2, allowing for the detection and analysis of TROP2 expression in cancer cells and tissues.Research on TROP2 has shown its involvement in promoting tumor growth, migration, and invasion, making it a potential biomarker for cancer prognosis and a target for developing targeted therapies. By using the Biotinylated Anti-TROP2 Antibody, researchers can gain valuable insights into the role of TROP2 in cancer biology and potentially develop new strategies for treating cancer.
Product Code:
HDLA037
Size:
100 µg
Clonality:
Monoclonal
Clone:
DM75
Synonyms:
TACSTD2, GA733-1, M1S1, TROP2
Applications:
ELISA, Flow Cyt
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Host Species:
Rabbit
Isotype:
Rabbit IgG
Reactivity:
Human
Purification Method:
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.
